These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11602818)

  • 1. Losartan inhibits the angiotensin II-induced modifications on fibrinolysis and matrix deposition by primary human vascular smooth muscle cells.
    Papakonstantinou E; Roth M; Kokkas B; Papadopoulos C; Karakiulakis G
    J Cardiovasc Pharmacol; 2001 Nov; 38(5):715-28. PubMed ID: 11602818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.
    van Leeuwen RT; Kol A; Andreotti F; Kluft C; Maseri A; Sperti G
    Circulation; 1994 Jul; 90(1):362-8. PubMed ID: 8026020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physiological regulation of MMPs and tPA/PAI in the arterial wall of rats by noradrenergic tone and angiotensin II.
    Dab H; Hachani R; Dhaouadi N; Hodroj W; Sakly M; Randon J; Bricca G; Kacem K
    J Renin Angiotensin Aldosterone Syst; 2012 Mar; 13(1):36-45. PubMed ID: 22071631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin IV stimulates plasminogen activator inhibitor-1 expression in proximal tubular epithelial cells.
    Gesualdo L; Ranieri E; Monno R; Rossiello MR; Colucci M; Semeraro N; Grandaliano G; Schena FP; Ursi M; Cerullo G
    Kidney Int; 1999 Aug; 56(2):461-70. PubMed ID: 10432384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans.
    Brown NJ; Agirbasli M; Vaughan DE
    Hypertension; 1999 Aug; 34(2):285-90. PubMed ID: 10454455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of angiotensin II receptor blocker on angiotensin II stimulated DNA synthesis of cultured human aortic smooth muscle cells.
    Makita S; Nakamura M; Yoshida H; Hiramori K
    Life Sci; 1995; 56(20):PL383-8. PubMed ID: 7723594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells.
    Sironi L; Calvio AM; Arnaboldi L; Corsini A; Parolari A; de Gasparo M; Tremoli E; Mussoni L
    Hypertension; 2001 Mar; 37(3):961-6. PubMed ID: 11244025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells.
    Guo YS; Wu ZG; Yang JK; Chen XJ
    Mol Med Rep; 2015 Mar; 11(3):1587-94. PubMed ID: 25405958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin II stimulates DNA and protein synthesis in vascular smooth muscle cells from human arteries: role of extracellular signal-regulated kinases.
    Touyz RM; Deng LY; He G; Wu XH; Schiffrin EL
    J Hypertens; 1999 Jul; 17(7):907-16. PubMed ID: 10419063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II induces the production of MMP-3 and MMP-13 through the MAPK signaling pathways via the AT(1) receptor in osteoblasts.
    Nakai K; Kawato T; Morita T; Iinuma T; Kamio N; Zhao N; Maeno M
    Biochimie; 2013 Apr; 95(4):922-33. PubMed ID: 23277113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of the 4G/5G PAI-1 genotype on angiotensin II-stimulated human endothelial cells and in patients with hypertension.
    Roncal C; Orbe J; Rodriguez JA; Belzunce M; Beloqui O; Diez J; Páramo JA
    Cardiovasc Res; 2004 Jul; 63(1):176-85. PubMed ID: 15194475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucose and insulin independently reduce the fibrinolytic potential of human vascular smooth muscle cells in culture.
    Pandolfi A; Iacoviello L; Capani F; Vitacolonna E; Donati MB; Consoli A
    Diabetologia; 1996 Dec; 39(12):1425-31. PubMed ID: 8960822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries.
    Brassard P; Amiri F; Schiffrin EL
    Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic effect of adrenal steroids and angiotensin II on plasminogen activator inhibitor-1 production.
    Brown NJ; Kim KS; Chen YQ; Blevins LS; Nadeau JH; Meranze SG; Vaughan DE
    J Clin Endocrinol Metab; 2000 Jan; 85(1):336-44. PubMed ID: 10634408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.
    Stoll M; Steckelings UM; Paul M; Bottari SP; Metzger R; Unger T
    J Clin Invest; 1995 Feb; 95(2):651-7. PubMed ID: 7860748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY.
    Touyz RM; He G; El Mabrouk M; Schiffrin EL
    Hypertension; 2001 Feb; 37(2 Pt 2):574-80. PubMed ID: 11230337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
    Erdem Y; Usalan C; Haznedaroğlu IC; Altun B; Arici M; Yasavul U; Turgan C; Cağlar S
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1071-6. PubMed ID: 10604482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappaB and activator protein 1 in a redox-sensitive manner.
    Browatzki M; Larsen D; Pfeiffer CA; Gehrke SG; Schmidt J; Kranzhofer A; Katus HA; Kranzhofer R
    J Vasc Res; 2005; 42(5):415-23. PubMed ID: 16103692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor-alpha-induced AT1 receptor upregulation enhances angiotensin II-mediated cardiac fibroblast responses that favor fibrosis.
    Peng J; Gurantz D; Tran V; Cowling RT; Greenberg BH
    Circ Res; 2002 Dec; 91(12):1119-26. PubMed ID: 12480812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin-mediated growth in aortic smooth muscle and the vascular renin-angiotensin system.
    Kamide K; Hori MT; Zhu JH; Barrett JD; Eggena P; Tuck ML
    Hypertension; 1998 Sep; 32(3):482-7. PubMed ID: 9740614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.